Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients

BACKGROUND: Levosimendan has been extensively used to treat heart failure (HF) for nearly 10 years, but data on levosimendan used in elderly patients with refractory HF remains limited. This study aimed to investigate the effects of levosimendan on elderly patients with intractable HF. MATERIAL/METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dengqing, Yao, Yuanqing, Qian, Jun, Huang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548701/
https://www.ncbi.nlm.nih.gov/pubmed/26289557
http://dx.doi.org/10.12659/MSM.893580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548701/
https://www.ncbi.nlm.nih.gov/pubmed/26289557
http://dx.doi.org/10.12659/MSM.893580

Ejemplares similares